Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,817 signal articles · 186 in last 24h · 123,864 total before filter · latest 1h ago
186last 24h
1220last 7d
202● bullish (7d)
141● bearish (7d)
205publishers
AllMacro210Earnings413M&A104Regulatory23Product10Analyst8
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
Insider Monkey14d agoneutral
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook

AbCellera Biologics Inc. (NASDAQ:ABCL) rallied for a third consecutive day on Monday to hit a new three-year high, after its drug candidate for hot flashes in menopausal women achieved strong clinical trial results, sparking long-term rosy growth prospects. In intra-day trading, the stock surged to a record high of $10.01 before trimming gains to end […]

Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
Insider Monkey14d agoneutral
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?

The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one of healthcare’s fastest-growing markets. Yet another competitive advantage for investors to […]

Intel (INTC) Tripled This Year, But Can a $15B Share Sale Stop the Momentum?
Insider Monkey14d agoneutral
Intel (INTC) Tripled This Year, But Can a $15B Share Sale Stop the Momentum?

Intel (NASDAQ:INTC) shares have nearly tripled this year, outrunning AMD (NASDAQ:AMD), Nvidia (NASDAQ:NVDA), and the Philadelphia Semiconductor Index’s nearly 75% climb. On August 10, the company said it would sell $15 billion of new stock to fund its push into contract chip manufacturing, and shares fell more than 4% in early trading. That marked a […]

Trump Vs. Musk: President Says EV Drivers ‘Have a Disease’
Benzinga14d agoneutral
Trump Vs. Musk: President Says EV Drivers ‘Have a Disease’

The relationship between Tesla Inc CEO Elon Musk and President Donald Trump has been mostly positive since their notorious spat last year. After all, the billionaire poured hundreds of millions of dollars into Trump’s 2024 campaign and remains a key...

3 Reasons We Love RBC Bearings (RBC)
StockStory14d agoneutral
3 Reasons We Love RBC Bearings (RBC)

RBC Bearings currently trades at $566.59 per share and has shown little upside over the past six months, posting a middling return of 3.4%. The stock also fell short of the S&P 500’s 10.9% gain during that period.

Market expert 'cautious' on AI trade, likes healthcare, energy stocks
Reuters Videos14d agoneutralVIDEO
Market expert 'cautious' on AI trade, likes healthcare, energy stocks

<body><p>STORY: "We think the fundamentals are positive," on healthcare companies, Isherwood said. "We also think AI tools have potential to help drug development accelerate."</p><p>But the AI trade itself is "concerning," he said.</p><p>"We've watched, actually the credit markets where we've seen Oracle CDS (credit default swaps) blow to levels consistent with where they were last in the financial crisis," Isherwood explained. "We've also seen Nvidia's tick up past 50 basis points, which we consider the market starting to show a little bit of stress, and warning that some of these players may not be able to pay their bills in future years."</p></body>